A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL (ACCL1033)

Service: Trial Number:
Principal Investigator: Conducted at:
Miller Children's & Women's Hospital Long Beach
Currently enrolling additional patients:
Age Range:
7-17 years; 18 years & up
Male & Female

The overall goal of this study is to compare the effects, good and/or bad, of a multi-component intervention designed to help people with acute lymphoblastic leukemia (ALL) take their maintenance medication as directed, throughout the use of an educational program. Patients who have been diagnosed with ALL receive maintenance therapy that includes taking a drug called 6MP by mouth. We hope to find out whether the educational intervention helps people to take their medication better than those receiving only education. In this study, patients will get either the multi-component intervention or you will be asked to watch an educational video. You will not get both. The outcome of incorporating a multi-component intervention vs. standard education will be assessed.